Overview

Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis

Status:
Completed
Trial end date:
2016-06-29
Target enrollment:
Participant gender:
Summary
This study assessed efficacy of secukinumab, compared to ustekinumab, in patients that have plaque-type psoriasis
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Antibodies, Monoclonal
Ustekinumab